Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Drug Information » Recently Approved Drugs » 1999
Medical Areas: Oncology

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Zofran ODT

Company: GlaxoWellcome
Approval Status: Approved January 1999
Treatment Area: Oncology

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.